Catherine Caserza

Catherine Caserza serves as the Director of Clinical Operations at Daiichi Sankyo, Inc. since December 2022, following a role as a Clinical Operations Consultant from August 2021 to November 2022. Prior experience includes serving as Senior Director of Clinical Operations at CytomX Therapeutics and Director roles at Pfizer, where responsibilities included leading clinical study teams and project management in clinical research. Catherine's earlier positions include Clinical Program Manager at Cerexa, Clinical Research Consultant at BioMarin, and Acting Global Clinical Program Manager at Novartis. Educational qualifications include a Master's in Public Health from the University of California, Berkeley, a Master's in Nursing Administration and Community Health Care from the University of California, San Francisco, and a Bachelor of Science in Nursing from the University of San Francisco.